2,8-Diacetylamino-1-tetralone → 8-Acetylamino-1-amino-6,7,8,9-tetrahydro-5H-benzocycloheptene-9-one
반응식
C([NH:4][C:5]1[C:10]2[C:11](=[O:20])[CH:12]([NH:16][C:17](=[O:19])[CH3:18])[CH2:13][CH2:14][CH2:15][C:9]=2[CH:8]=[CH:7][CH:6]=1)(=O)C.C(NC1CCC2C(=C(NC(=O)C)C=CC=2)C1=O)(=O)C>>[C:17]([NH:16][CH:12]1[C:11](=[O:20])[C:10]2[C:5]([NH2:4])=[CH:6][CH:7]=[CH:8][C:9]=2[CH2:15][CH2:14][CH2:13]1)(=[O:19])[CH3:18]참가 물질
3
실험 절차
The reaction was carried out in the same manner as in Example 1-(4), except that 115 mg of the compound prepared in (3) above was used instead of 2,8-diacetylamino-1-tetralone of Example 1-(4). The product was post-treated to produce 90 mg of the title compound.
후처리
- additionThe product was post-treated
출처 및 근거
- ORD 기록
- ord-02f5937204324797bd742880b1a85a72
- 출처 데이터셋
- uspto-grants-1997_08
- 특허 번호
- US05658920
반응 노트
불러오는 중…